Search research articles
Contact Us
Filters
Showing results (31-40 of 54) with videos related to
Page
of 6
Sort By:
Vaccine
|
March 6, 2018
Vaccine-preventable disease incidence of pneumococcal conjugate vaccine in the Finnish invasive pneumococcal disease vaccine trial
Arto A Palmu, Jukka Jokinen, Heta Nieminen, et al.
Human Vaccines
|
November 4, 2011
Immunogenicity, reactogenicity and safety of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in Mexican infants
Guillermo M Ruiz-Palacios, M Lourdes Guerrero, Lorena Hernández-Delgado, et al.
Scientific Reports
|
August 18, 2021
Efficacy and safety of primary, early and late needle-knife fistulotomy for biliary access
Jorge Canena, Luís Lopes, João Fernandes, et al.
The Pediatric Infectious Disease Journal
|
August 19, 2015
Effectiveness of the Ten-valent Pneumococcal Conjugate Vaccine Against Tympanostomy Tube Placements in a Cluster-randomized Trial
Arto A Palmu, Jukka Jokinen, Heta Nieminen, et al.
Scandinavian Journal of Gastroenterology
|
August 6, 2021
Outcomes of single-endoscopist-performed needle-knife fistulotomy for selective biliary access in 842 consecutive patients: learning curve and changes over a 14-year period in a retrospective study
João Fernandes, Jorge Canena, Gonçalo Alexandrino, et al.
Expert Review of Vaccines
|
April 21, 2017
Immunization with 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) according to different schedules in infants in South Africa: a phase III trial
Shabir A Madhi, Anthonet Koen, Lisa Jose, et al.
Journal of the Pediatric Infectious Diseases Society
|
April 30, 2016
Effectiveness of the 10-Valent Pneumococcal Nontypeable Haemophilus influenzae Protein D-Conjugated Vaccine (PHiD-CV) Against Carriage and Acute Otitis Media-A Double-Blind Randomized Clinical Trial in Finland
Timo Vesikari, Aino Forsten, Ilkka Seppä, et al.
Lancet (London, England)
|
November 20, 2012
Effectiveness of the ten-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) against invasive pneumococcal disease: a cluster randomised trial
Arto A Palmu, Jukka Jokinen, Dorota Borys, et al.
The Lancet. Infectious Diseases
|
November 30, 2013
Effect of pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) on outpatient antimicrobial purchases: a double-blind, cluster randomised phase 3-4 trial
Arto A Palmu, Jukka Jokinen, Heta Nieminen, et al.
Digestive Diseases and Sciences
|
November 23, 2021
Factors Influencing Performance of Cholangioscopy-Guided Lithotripsy Including Available Different Technologies: A Prospective Multicenter Study with 94 Patients
Gonçalo Alexandrino, Luís Lopes, João Fernandes, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 54) with videos related to
Sort By:
Page
of 6
Vaccine
|
March 6, 2018
Vaccine-preventable disease incidence of pneumococcal conjugate vaccine in the Finnish invasive pneumococcal disease vaccine trial
Arto A Palmu, Jukka Jokinen, Heta Nieminen, et al.
Human Vaccines
|
November 4, 2011
Immunogenicity, reactogenicity and safety of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in Mexican infants
Guillermo M Ruiz-Palacios, M Lourdes Guerrero, Lorena Hernández-Delgado, et al.
Scientific Reports
|
August 18, 2021
Efficacy and safety of primary, early and late needle-knife fistulotomy for biliary access
Jorge Canena, Luís Lopes, João Fernandes, et al.
The Pediatric Infectious Disease Journal
|
August 19, 2015
Effectiveness of the Ten-valent Pneumococcal Conjugate Vaccine Against Tympanostomy Tube Placements in a Cluster-randomized Trial
Arto A Palmu, Jukka Jokinen, Heta Nieminen, et al.
Scandinavian Journal of Gastroenterology
|
August 6, 2021
Outcomes of single-endoscopist-performed needle-knife fistulotomy for selective biliary access in 842 consecutive patients: learning curve and changes over a 14-year period in a retrospective study
João Fernandes, Jorge Canena, Gonçalo Alexandrino, et al.
Expert Review of Vaccines
|
April 21, 2017
Immunization with 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) according to different schedules in infants in South Africa: a phase III trial
Shabir A Madhi, Anthonet Koen, Lisa Jose, et al.
Journal of the Pediatric Infectious Diseases Society
|
April 30, 2016
Effectiveness of the 10-Valent Pneumococcal Nontypeable Haemophilus influenzae Protein D-Conjugated Vaccine (PHiD-CV) Against Carriage and Acute Otitis Media-A Double-Blind Randomized Clinical Trial in Finland
Timo Vesikari, Aino Forsten, Ilkka Seppä, et al.
Lancet (London, England)
|
November 20, 2012
Effectiveness of the ten-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) against invasive pneumococcal disease: a cluster randomised trial
Arto A Palmu, Jukka Jokinen, Dorota Borys, et al.
The Lancet. Infectious Diseases
|
November 30, 2013
Effect of pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) on outpatient antimicrobial purchases: a double-blind, cluster randomised phase 3-4 trial
Arto A Palmu, Jukka Jokinen, Heta Nieminen, et al.
Digestive Diseases and Sciences
|
November 23, 2021
Factors Influencing Performance of Cholangioscopy-Guided Lithotripsy Including Available Different Technologies: A Prospective Multicenter Study with 94 Patients
Gonçalo Alexandrino, Luís Lopes, João Fernandes, et al.
Page
of 6